Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 17, 2018 - Issue 6
Submit an article Journal homepage
352
Views
8
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

The safety of indacaterol for the treatment of COPD

Evgenios I. MetaxasDepartment of Pulmonary Medicine, Evaggelismos General Hospital, Athens, Greece;Department of Pulmonary Medicine, Polyclinic Ygia Hospital, Limassol, CyprusCorrespondence[email protected]
View further author information
&
Evangelos BalisDepartment of Pulmonary Medicine, Evaggelismos General Hospital, Athens, GreeceView further author information
Pages 637-642 | Received 14 Feb 2018, Accepted 30 Apr 2018, Published online: 09 May 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now
Erminia Ridolo, Irene Pellicelli, Bruna Gritti & Cristoforo Incorvaia. (2019) Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. Patient Preference and Adherence 13, pages 145-150.
Read now

Articles from other publishers (6)

Alberto Papi, Konstantinos Kostikas, Ivan Nikolaev & Ioannis Kottakis. (2022) Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma. Current Respiratory Medicine Reviews 18:2, pages 77-85.
Crossref
Cui Tang, Chen-xi Ou-yang, Wen-jing Chen, Chan Zou, Jie Huang, Chang Cui, Shuang Yang, Can Guo, Xiao-yan Yang, Yu Lin, Qi Pei & Guo-ping Yang. (2022) Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model. European Journal of Pharmaceutical Sciences 168, pages 106055.
Crossref
Tomoko Taniguchi, Dong Wang, Hajime Yoshisue, Makoto Nagasaki & Takayoshi Sasajima. (2021) Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan. Internal Medicine 60:15, pages 2385-2394.
Crossref
Ailin Yang, Ganggang Yu, Yanjun Wu & Haoyan Wang. (2021) Role of β2-adrenergic receptors in chronic obstructive pulmonary disease. Life Sciences 265, pages 118864.
Crossref
Gang Xing, Anthony Yiu-Ho Woo, Li Pan, Bin Lin & Mao-Sheng Cheng. (2020) Recent Advances in β 2 -Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure . Journal of Medicinal Chemistry 63:24, pages 15218-15242.
Crossref
David Miller, Soniya Vaidya, Juergen Jauernig, Brian Ethell, Kristina Wagner, Rajkumar Radhakrishnan & Hanns-Christian Tillmann. (2020) Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients. Respiratory Research 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.